Agios Pharmaceuticals, Inc. financial data

Symbol
AGIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
88 Sidney Street, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.27 K % -18.9%
Quick Ratio 32.2 % +132%
Debt-to-equity 13.9 % +17.2%
Return On Equity -41.4 % -105%
Return On Assets -36.4 % -101%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56.8 M shares +2.15%
Common Stock, Shares, Outstanding 56.8 M shares +2.18%
Entity Public Float 1.56 B USD +29.8%
Common Stock, Value, Issued 71 K USD +1.43%
Weighted Average Number of Shares Outstanding, Basic 56.4 M shares +2.02%
Weighted Average Number of Shares Outstanding, Diluted 56.4 M shares +2.02%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 29.4 M USD +54.6%
Research and Development Expense 297 M USD +7.13%
General and Administrative Expense 29.1 M USD +7.26%
Costs and Expenses 422 M USD +6.24%
Operating Income (Loss) -393 M USD -3.81%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -352 M USD -51.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -353 M USD -61.7%
Earnings Per Share, Basic -6.31 USD/shares -59.3%
Earnings Per Share, Diluted -6.31 USD/shares -59.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 119 M USD +14%
Cash, Cash Equivalents, and Short-term Investments 714 M USD -28.6%
Inventory, Net 23.1 M USD +103%
Assets, Current 664 M USD -16.2%
Property, Plant and Equipment, Net 14.1 M USD -34.1%
Operating Lease, Right-of-Use Asset 51.6 M USD -17.5%
Other Assets, Noncurrent 4.06 M USD +2.53%
Assets 850 M USD -26.2%
Accounts Payable, Current 11.2 M USD +28.8%
Employee-related Liabilities, Current 5.4 M USD -18.8%
Accrued Liabilities, Current 25.1 M USD +11.9%
Contract with Customer, Liability, Current 2.5 M USD
Liabilities, Current 51.7 M USD +14.6%
Operating Lease, Liability, Noncurrent 52.9 M USD -22.5%
Other Liabilities, Noncurrent 1.16 M USD -12%
Liabilities 106 M USD -7.83%
Retained Earnings (Accumulated Deficit) -904 M USD -63.9%
Stockholders' Equity Attributable to Parent 744 M USD -28.2%
Liabilities and Equity 850 M USD -26.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -99.9 M USD -4.92%
Net Cash Provided by (Used in) Financing Activities 5.86 M USD +138%
Net Cash Provided by (Used in) Investing Activities 125 M USD +116%
Common Stock, Shares Authorized 125 M shares 0%
Common Stock, Shares, Issued 73 M shares +1.69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 30.6 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 119 M USD +14%
Deferred Tax Assets, Valuation Allowance 380 M USD +28.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 395 M USD +25%
Operating Lease, Liability 68.3 M USD -17%
Depreciation 6.6 M USD -21.4%
Payments to Acquire Property, Plant, and Equipment 141 K USD -64.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -345 M USD -57.9%
Lessee, Operating Lease, Liability, to be Paid 76.4 M USD -19.3%
Property, Plant and Equipment, Gross 67.6 M USD -7.45%
Operating Lease, Liability, Current 15.4 M USD +10.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.2 M USD +3.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.5 M USD +4.54%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.03 M USD -34.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.8 M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 64.1 M USD +94.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25 M shares 0%
Unrecognized Tax Benefits 28.6 M USD +9.12%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.48 M USD -83.2%
Operating Lease, Payments 18.3 M USD +2.95%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 43.9 M USD -0.15%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%